Contraindicated (1)bortezomib will raise the stage or influence of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Powerful or moderate CYP2C19 inhibitors might boost mavacamten systemic publicity, leading to heart failure due to systolic dysfunction. Remedy triggers peripheral neuropathy (predominantly sensory); even so, situations of significant sensory... https://h-89dihydrochloride22098.digitollblog.com/26600608/the-5-second-trick-for-dup-747